Anthem Biosciences (NSE:ANTHEM) OCF Margin %: 0.00% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ANTHEM Anthem Biosciences Ltd NSE:ANTHEM
34 GF Score
Price ₹747.65
! 2 Warning Signs
View Full Analysis

What is Anthem Biosciences OCF Margin %?

Anthem Biosciences NSE:ANTHEM -0.93% 34 OCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates NSE:ANTHEM with a GF Score™ of 34/100. The stock has 2 warning signs investors should review. Among 950 Biotechnology companies, Anthem Biosciences ranks better than 96.21% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Anthem Biosciences's Cash Flow from Operations for the three months ended in Mar. 2026 was ₹0 Mil. Anthem Biosciences's Revenue for the three months ended in Mar. 2026 was ₹6,109 Mil. Therefore, Anthem Biosciences's OCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Anthem Biosciences's current OCF Yield % is 1.99%.

The historical rank and industry rank for Anthem Biosciences's OCF Margin % or its related term are showing as below:

NSE:ANTHEM' s OCF Margin % Range Over the Past 10 Years
Min: 9.87   Med: 27.04   Max: 39.75
Current: 53.31

During the past 5 years, the highest OCF Margin % of Anthem Biosciences was 39.75%. The lowest was 9.87%. And the median was 27.04%.

NSE:ANTHEM's OCF Margin % is ranked better than
96.21% of 950 companies
in the Biotechnology industry
Industry Median: -65.71 vs NSE:ANTHEM: 53.31

Anthem Biosciences OCF Margin % Related Terms

Anthem Biosciences OCF Margin % Historical Data

* Premium members only.

The historical data trend for Anthem Biosciences's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anthem Biosciences OCF Margin % Chart

Anthem Biosciences Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
OCF Margin %
27.04 28.95 9.87 14.67 39.75

Anthem Biosciences Quarterly Data
Mar22 Mar23 Mar24 Sep24 Dec24 Mar25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

NSE:ANTHEM vs VRTX, REGN, ALNY: OCF Margin % Comparison

For the Biotechnology subindustry, Anthem Biosciences's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Anthem Biosciences OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Anthem Biosciences's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Anthem Biosciences's OCF Margin % falls into.


NSE:ANTHEM
34GF Score
Anthem Biosciences Ltd NSE:ANTHEM
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Anthem Biosciences OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Anthem Biosciences's OCF Margin for the fiscal year that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=8444.85/21243.33
=39.75 %

Anthem Biosciences's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=0/6109.43
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Anthem Biosciences (NSE:ANTHEM) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Anthem Biosciences and its competitors. Over the past decade, Anthem Biosciences' OCF Margin % has ranged from 9.87 to 39.75. According to the industry distribution chart, Anthem Biosciences ranks #36 out of 950 companies in the Biotechnology industry, placing it in the top 3.8%.
Is Anthem Biosciences' OCF Margin % too high?
Anthem Biosciences' current OCF Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 9.87 to a high of 39.75. Based on the distribution chart, Anthem Biosciences ranks #36 out of 950 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Anthem Biosciences has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Anthem Biosciences' OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Anthem Biosciences ranks #36 out of 950 companies for OCF Margin %. This places Anthem Biosciences in the top 4% of its industry — outperforming the majority of peers. Historically, Anthem Biosciences' own OCF Margin % has ranged from 9.87 to 39.75 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Anthem Biosciences and its competitors. Anthem Biosciences's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anthem Biosciences stock overvalued right now?
Anthem Biosciences (NSE:ANTHEM) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Anthem Biosciences' overall GF Score™ is 34/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Anthem Biosciences (NSE:ANTHEM), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Anthem Biosciences Business Description

Other Exchanges 544449:India
Address No. 49, F1 & F2, Canara Bank Road, Bommasandra Industrial Area, Phase 1, Bommasandra, Bangalore, KA, IND, 560 099
Anthem Biosciences Ltd is an innovation-driven and technology-focused Contract Research, Development and Manufacturing Organization (CRDMO) with fully integrated operations spanning across drug discovery, development and manufacturing. It is one of the few companies in India with integrated New Chemical Entity (NCE) and New Biological Entity (NBE) capabilities across drug discovery, development, and commercial manufacturing. As a one-stop service provider, It serves a range of customers, encompassing innovator-focused emerging biotech and large pharmaceutical companies globally.
34GF Score

Get the complete analysis for NSE:ANTHEM

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹747.65
Price